Stock Events

Stock Events

Comera Life Sciences

$0.000001

4

+$0.00+0% Tuesday 16:21

+$0.00+9,900%Tuesday 20:15After hours

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

30.74

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

14NovExpected

Q1 2021

Q2 2021

Q3 2021

Q4 2021

Q1 2022

Q2 2022

Q3 2022

-1.14

-0.65

-0.17

0.32

Expected EPS

N/A

Actual EPS

-0.2

Financials

-3,266.08%Profit Margin

Unprofitable

2021

2022

1.03MRevenue

-33.68MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CMRAW. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Pfizer is a global pharmaceutical company that competes with Comera Life Sciences in the development and commercialization of biologics and biosimilars, which are core to Comera's business model.

Merck operates in the pharmaceutical and biopharmaceutical sectors, directly competing with Comera Life Sciences in the research, development, and marketing of drugs in similar therapeutic areas.

Johnson & Johnson

Johnson & Johnson, through its pharmaceutical segment, competes with Comera Life Sciences in developing innovative treatments, including biologics, across various healthcare fields.

Amgen focuses on human therapeutics, including biologics, in areas overlapping with Comera Life Sciences' interests, making it a direct competitor in the biopharmaceutical market.

Bristol-Myers Squibb

Bristol Myers Squibb is involved in discovering, developing, and delivering innovative medicines, including biologics, that compete with Comera Life Sciences' product offerings.

AbbVie operates in the biopharmaceutical field, focusing on developing and marketing advanced therapies that compete with Comera Life Sciences' research and development in biologics.

Novartis is a global healthcare company that competes with Comera Life Sciences in the development and marketing of patented pharmaceuticals, including biologics and biosimilars.

Roche Holding AG, through its pharmaceuticals division, competes in the biotechnology and biopharmaceutical sectors, directly challenging Comera Life Sciences in the biologics market.

Sanofi is a global biopharmaceutical company focusing on human health, directly competing with Comera Life Sciences in the development of biologics and specialty care products.

Gilead Sciences

Gilead Sciences is a biopharmaceutical company that develops and markets innovative therapeutics in areas of unmet medical need, competing with Comera Life Sciences in the biologics space.

About

Comera Life Sciences Holdings, Inc. is an early-stage life sciences company dedicated to developing its own innovative therapeutics. These treatments leverage its unique SQore formulation platform, which is engineered to convert biologics typically administered intravenously (IV) into convenient subcutaneous (SQ) versions. The company's pipeline currently features two primary drug candidates: CLS-001, an improved biologic in preclinical development, targets Crohn's and Ulcerative Colitis; and CLS-002, also in preclinical stages, is an enhanced biologic aimed at various oncological indications. Established in 2014, Comera Life Sciences is based in Woburn, Massachusetts.

Show more...

CEO

Michael G. Campbell

Employees

12

Country

United States

ISIN

US20037C1163

Listings

0 Comments

Share your thoughts

FAQ

What is Comera Life Sciences stock price today?▼

The current price of CMRAW is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Comera Life Sciences stock price performance more closely on the chart.

What is Comera Life Sciences stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Comera Life Sciences stocks are traded under the ticker CMRAW.

What is Comera Life Sciences market cap?▼

Today Comera Life Sciences has the market capitalization of 30.74

What is Comera Life Sciences revenue for the last year?▼

Comera Life Sciences revenue for the last year amounts to 1.03M USD.

What is Comera Life Sciences net income for the last year?▼

CMRAW net income for the last year is -33.68M USD.

How many employees does Comera Life Sciences have?▼

As of September 04, 2026, the company has 12 employees.

In which sector is Comera Life Sciences located?▼

Comera Life Sciences operates in the Health & Wellness sector.

When did Comera Life Sciences complete a stock split?▼

The last stock split for Comera Life Sciences was on May 21, 2003 with a ratio of 1:800.

Where is Comera Life Sciences headquartered?▼

Comera Life Sciences is headquartered in Woburn, United States.